abrdn Life Sciences Investors (HQL) To Go Ex-Dividend on May 21st

abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Monday, May 11th. Stockholders of record on Thursday, May 21st will be given a dividend of 0.56 per share on Saturday, May 30th. This represents a c) annualized dividend and a dividend yield of 12.7%. The ex-dividend date is Thursday, May 21st.

abrdn Life Sciences Investors Price Performance

Shares of HQL opened at $17.66 on Tuesday. The business has a 50-day moving average of $17.16 and a 200 day moving average of $17.01. abrdn Life Sciences Investors has a fifty-two week low of $12.12 and a fifty-two week high of $18.46.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.